LYMPH NODE DISSECTION IN PATIENTS WITH RENAL-CELL CARCINOMA OF THE PROS AND CONS
https://doi.org/10.21886/2308-6424-2015-0-4-43-49
Abstract
Radical nephrectomy involves removal of the kidney with paranephrium within Gerota's fascia. The need to perform adrenalectomy, the appropriateness and extent of lymph node dissection remains controversial. The results of treatment of patients with renal cell carcinoma are in the article. In this group, 38.6% of patients had vascular invasion. Nephrectomy was performed from laparotomy, the proximal and distal boundaries of dissection became superior mesenteric artery and the aortic bifurcation. Morphological examination did not reveal highly differentiated tumors. The frequency of renal capsule and perinephric invasion reached 40.9%, unchanged adrenal - 9.1%, regional lymph nodes - 22.7%. This is higher than the published data on the frequency of neoplastic lesions of the lymph nodes. Patients affected appeared to 2 lymph nodes. In conclusion, the authors concluded that such an aggressive approach could improve treatment outcomes.
About the Authors
S. V. ShkodkinRussian Federation
Y. B. Idashkin
Russian Federation
A. V. Lyubushkin
Russian Federation
S. A. Fironov
Russian Federation
References
1. Клиническая онкоурология (под редакцией профессора Б.П. Матвеева), Москва 2011, стр. 56.
2. Опухоли мочеполовой системы (под редакцией профессора Ю.Г. Аляе- ва), Москва «Геотар-Медиа», стр. 439.
3. EAU Full Guideline Renal cell carcinoma, - 2015 p. 24.
4. Bekema HJ, MacLennan S, Imamura M, et al. Systematic review of adrenalectomy and lymph node dissection in locally advanced renal cell carcinoma. Eur Urol 2013 Nov;64(5):799-810. http://www.ncbi.nlm.nih.gov/pubmed/23643550
5. Blom JH, Van Poppel H, Marйchal JM, et al. Radical Nephrectomy with and without Lymph-Node-Dissection: Final Results of European Organization for Research and Treatment of Cancer (EORTC) Randomized Phase 3 Trial 30881. Eur Urol 2009 Jan;55(1):28-34. http://www.ncbi.nlm.nih.gov/pubmed/18848382
6. Tsui KH, Shvarts O, Smith RB, et al. Prognostic indicators for renal cell carcinoma: a multivariate analysis of 643 patients using the revised 1997 TNM staging criteria. J Urol 2000;163:1090-5. quiz 1295. http://www.ncbi.nlm.nih.gov/ pubmed/10737472.
7. Capitanio U, Becker F, Blute ML, et al. Lymph node dissection in renal cell carcinoma. Eur Urol 2011 Dec;60(6):1212-20. http://www.ncbi.nlm.nih.gov/pubmed/ 21940096.
8. Babaian KN, Kim DY, Kenney PA, Wood CG Jr, Wong J, Sanchez C, Fang JE, Gerber JA, Didic A, Wahab A, Golla V, Torres C, Tamboli P, Qiao W, Matin SF, Wood CG, Karam JA. Preoperative predictors of pathological lymph node metastasis in patients with renal cell carcinoma undergoing retroperitoneal lymph node dissection. J Urol. 2015 Apr;193(4):1101-7. doi: 10.1016/j.juro.2014.10.096. Epub 2014 Oct 25. PMID: 25390078
9. Capitanio U, Suardi N, Matloob R, Roscigno M, Abdollah F, Di Trapani E, Moschini M, Gallina A, Salonia A, Briganti A, Montorsi F, Bertini R. Extent of lymph node dissection at nephrectomy affects cancer-specific survival and metastatic progression in specific sub-categories of patients with renal cell carcinoma (RCC). BJU Int. 2014 Aug;114(2):210-5. doi: 10.1111/bju.12508. Epub 2014 May 22. PMID: 24854206
10. Barrisford GW, Gershman B, Blute ML Sr. The role of lymphadenectomy in the management of renal cell carcinoma. World J Urol. 2014 Jun;32(3):643-9. doi: 10.1007/s00345-014-1294-5. Epub 2014 Apr 11. Review. PMID: 24723269
Review
For citations:
Shkodkin S.V., Idashkin Y.B., Lyubushkin A.V., Fironov S.A. LYMPH NODE DISSECTION IN PATIENTS WITH RENAL-CELL CARCINOMA OF THE PROS AND CONS. Urology Herald. 2015;(4):43-49. (In Russ.) https://doi.org/10.21886/2308-6424-2015-0-4-43-49